Endogenous cannabinoid signaling is essential for stress adaptation

Area of Science:

• Neuroendocrinology
• Stress Physiology
• Cannabinoid Signaling

Background:

• Glucocorticoid hormones mediate short-term adaptive stress responses.
• Prolonged glucocorticoid secretion due to repeated stress can be detrimental.
• The role of endocannabinoid signaling in neuroendocrine stress adaptation is unclear.

Purpose of the Study:

• To investigate the role of endocannabinoid ligands anandamide (AEA) and 2-arachidonoylglycerol (2-AG) in hypothalamic-pituitary-adrenal (HPA) axis habituation to repeated stress.
• To elucidate how AEA and 2-AG signaling differentially regulate the neuroendocrine response to chronic stress.

Main Methods:

• Analysis of AEA and 2-AG levels in the corticolimbic stress circuit following repeated stress exposure.
• Pharmacological manipulation of AEA hydrolysis and cannabinoid receptor 1 (CB1) activity.
• Assessment of corticosterone secretion and HPA axis activity.

Main Results:

• Repeated stress persistently decreased AEA levels across the corticolimbic circuit.
• 2-AG levels selectively increased in the amygdala in a stress-dependent manner.
• Inhibition of AEA hydrolysis prevented basal hypersecretion of corticosterone; CB1 antagonism blocked stress-induced HPA axis decline.

Conclusions:

• Endocannabinoid signaling plays a critical role in the habituation of the HPA axis response to repeated stress.
• AEA and 2-AG differentially modulate distinct components of the adrenocortical response to chronic stress.
• Targeting endocannabinoid pathways may offer strategies for managing stress-related disorders.